| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 73.136 | 21.659 | 73.274 | 86.270 | 105.725 | 119.023 | 79.162 | 36.266 | 34.814 | 111 |
| Total Income - EUR | 73.314 | 21.660 | 73.271 | 86.271 | 105.725 | 119.023 | 79.163 | 36.266 | 34.814 | 111 |
| Total Expenses - EUR | 130.045 | 57.217 | 87.273 | 78.861 | 81.886 | 80.262 | 90.940 | 60.044 | 34.490 | 28.627 |
| Gross Profit/Loss - EUR | -56.730 | -35.558 | -14.002 | 7.409 | 23.839 | 38.761 | -11.777 | -23.777 | 324 | -28.517 |
| Net Profit/Loss - EUR | -56.573 | -35.575 | -17.799 | 6.547 | 22.859 | 37.577 | -12.569 | -24.140 | -24 | -28.520 |
| Employees | 2 | 5 | 5 | 5 | 5 | 6 | 3 | 2 | 1 | 2 |
Check the financial reports for the company - Analitic Laboramed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 41.760 | 35.471 | 29.214 | 25.042 | 21.340 | 22.941 | 14.299 | 12.623 | 10.553 | 8.728 |
| Current Assets | -37.116 | 5.291 | 27.475 | 36.519 | 54.045 | 52.692 | 12.296 | 8.352 | 9.397 | 11.223 |
| Inventories | 375 | 20.745 | 10.782 | 11.007 | 1.368 | 4.149 | 0 | 0 | 0 | 0 |
| Receivables | 5.436 | 14.577 | 15.436 | 21.236 | 39.988 | 47.092 | 11.540 | 7.520 | 7.751 | 7.708 |
| Cash | -42.927 | -30.031 | 1.258 | 4.275 | 12.690 | 1.451 | 757 | 832 | 1.646 | 3.515 |
| Shareholders Funds | -12.256 | -47.705 | -64.697 | -56.963 | -33.000 | 5.202 | -7.482 | -31.645 | -31.573 | -59.916 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 16.900 | 90.898 | 126.087 | 126.143 | 121.362 | 89.169 | 53.881 | 52.620 | 51.522 | 79.868 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Analitic Laboramed Srl